| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 476 |
| 1 | LAMIVUDINE ORAL | 476 |
| 2 | RITONAVIR | 460 |
| 3 | ZIDOVUDINE | 413 |
| 4 | NEVIRAPINE | 314 |
| 5 | LOPINAVIR AND RITONAVIR | 291 |
| 6 | ABACAVIR SULFATE | 286 |
| 7 | TENOFOVIR DISOPROXIL FUMARATE | 277 |
| 8 | RITONAVIR 100 MG | 263 |
| 9 | DARUNAVIR | 244 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AESCULUS HIPPOCASTANUM WHOLE | 8 | 0.1067 |
| 1 | AGRIMONIA EUPATORIA | 8 | 0.1053 |
| 2 | CENTAURIUM ERYTHRAEA | 8 | 0.1039 |
| 3 | ZIDOVUDINE | 413 | 0.0398 |
| 4 | ETRAVIRINE | 175 | 0.0394 |
| 5 | NELFINAVIR MESYLATE | 77 | 0.0368 |
| 6 | NEVIRAPINE | 314 | 0.0349 |
| 7 | ABACAVIR SULFATE | 286 | 0.0294 |
| 8 | DARUNAVIR 600 MG | 146 | 0.0236 |
| 9 | LOPINAVIR AND RITONAVIR | 291 | 0.0216 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 512 | 0.0213 |
| 1 | Protease Inhibitor [EPC] | 630 | 0.0142 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 596 | 0.0121 |
| 3 | Cytochrome P450 3A Inhibitor [EPC] | 653 | 0.0108 |
| 4 | CCR5 Co-receptor Antagonist [EPC] | 24 | 0.0105 |
| 5 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 86 | 0.0083 |
| 6 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 828 | 0.0075 |
| 7 | Leptin Analog [EPC] | 3 | 0.0024 |
| 8 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 3 | 0.0024 |
| 9 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |